Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion type Assertion NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_head.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion description "[PC-3 and LNCaP prostate carcinoma cell lines were transiently transfected with wild-type Egr-1 expression plasmid (pCMV-Egr-1) and treated with cisplatin and TPA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_provenance.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion evidence source_evidence_literature NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_provenance.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion SIO_000772 21617851 NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_provenance.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion wasDerivedFrom befree-2016 NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_provenance.
- NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_assertion wasGeneratedBy ECO_0000203 NP897204.RA9nUxiCn4a_5UQk85pE-7NCbJpaelirOu4RtxX4dTaOk130_provenance.